luni, 17 mai 2010

Nokia E61i

Acum vreo cateva luni (mai precis 3 luni) am plecat pana la Deva sa imi iau telefonul mobil despre care vorbesc acum. De ce am mers pana acolo ? Pentru ca era mult mai bun decat vechiul telefon si il dadea foarte ieftin. Plus ca nu mai iesisem de ceva vreme din judetul Timis, asa ca vroiam sa mai schimb peisajul. Am stat putin la Deva, dar s-a meritat. Telefonul care l-am luat, mai exact Nokia E61i s-a dovedit a fi foarte util fie ca aveam ceva de lucru si nu aveam laptopul la indemana, fie ca vroiam sa ascult muzica sau sa fac ceva poze de prin natura.
In cele 3 luni de cand il am si-a facut pe deplin treaba, bateria tine mai mult de 4 zile in cazul in care nu il folosesti foarte mult. Daca il folosesti vreo 2-3 ore pe zi (cumulat), iti tine bateria vreo 2-3 zile. Si asa decent.
Eu l-am incercat si a meritat. Ai avut vreodata Nokia E61i ?

sâmbătă, 1 mai 2010

Linku' de 1 mai

Pentru ca tot este 1 mai si e ziua muncii, ma plictisesc. Afara e o caldura molesitoare, noroc cu camera in care
De pe Harta Turistului am cateva materiale pentru voi: Harta Simleul Silvaniei, Harta Zalau, Harta Jibou, Harta Cehu Silvaniei si un material interesant despre una dintre cele mai mici tari din Africa, mai exact Djibouti.

De pe Ora Sportiva avem cateva meciuri (mai bine zis am o groaza de meciuri de vineri seara) de vineri seara, 30 Aprilie 2010:
Din Franta: Auxerre - Marseille 0-0
Din Copa Libertadores: Once Caldas - Club Liberdad 0-0 si Alianza Lima - Universidad de Chile 0-1
Din Argentina: River Plate - Velez 2-1, Tigre - Racing Club 1-2, Rosario - Godoy Cruz 1-0 si Gimnasia La Plata - Lanus 0-0
Din Rusia: Anzhi Makhachkala - Krylya Sovetov 0-0
Din Ucraina: Vorskla - Arsenal Kiev 1-5 si Metalurg Doneth - Zorya Luhansk 0-0
Din Belgia: Zulte Waregem - Anderlecht 0-0
Din Cehia: Slovacko - Mlada Boleslav 1-0
Din Austria: Rapid Viena - Kapfenberger 5-3
Si binenteles si cele 2 meciuri disputate aseara in Liga 1: Astra - CFR Cluj 1-0 si Gloria Bistrita - Pandurii Targu Jiu 1-0

Nu am terminat cu linkurile inca, trebuie sa va mai dau si ceva linkuri de health si anatomie de pe PhysioAnatomy nu ? Pentru ziua de 1 mai avem doar 2 linkuri, una legata de efectele alcoolului asupra organismului si despre primul ajutor in plagi.

miercuri, 20 ianuarie 2010

Pharmacology - Treating Cancer (Armitage)

Two major areas are considered in this discussion of pharmacologic strategies for high-dose therapy (HDT). The first is the rational basis for the selection of the chemotherapeutic agents to be used in myeloablative regimens for the treatment of cancer and other diseases. The second is the use of pharmacokinetic measurements and dose adjustment to ensure adequate antitumor and myeloablative effect while avoiding drug exposures that produce intolerable toxicity.

INITIAL HIGH-DOSE REGIMENS

The initial type of marrow transplant developed was allogeneic bone marrow transplantation (ALBMT). The two purposes of the preparative chemotherapeutic regimen for ALBMT are to sufficiently eradicate the endogenous marrow to allow complete engraftment of the allogenic marrow being infused and to eradicate the tumor either completely or to a sufficient degree to allow the complete eradication of persisting tumor by an immune response to the residual tumor. That the immune response can fulfill such a role is indicated by the better long-term tumor-free survival in patients undergoing ALBMT as opposed to autologous bone marrow transplantation using the same preparative regimens for lymphomas and leukemias. This experience has also established the paradigm of the combination of chemotherapy followed by immunotherapy for tumor eradication. Recently, the concept of “transplant-lite” has been introduced by Khouri et al. This concept utilizes relatively nontoxic regimens, such as fludarabine phosphate (Fludara) and a modest dose of cyclophosphamide, or fludarabine, cisplatin (Platinol), and cytarabine (Cytosar-U) to produce sufficient immunosuppression for engraftment of an allogeneic stem cell infusion from HLA-identical siblings.
The first agent used for BMT for malignancy was total-body irradiation (TBI) alone . While TBI eradicated the endogenous marrow, it was insufficient to eradicate the leukemias being treated. High-dose cyclophosphamide was also initially used as a single agent but did not consistently eradicate the endogenous marrow or the leukemia in patients. The combinations of high-dose cyclophosphamide plus TBI or high-dose cyclophosphamide plus the alkylating agent busulfan (Myleran) soon became the two most common regimens for ALBMT for leukemias, as well as for lymphomas. Cyclophosphamide and busulfan have also been used successfully for HDT and autotransplant for leukemias, lymphomas, and solid tumors.

miercuri, 11 noiembrie 2009

Masks against AH1N1

Well, there were reported a lot of cases of AH1N1 flu virus in Romania in the latest months and because people are scared of this virus, they've started buying masks. The producers made a lot of profit of it, but now the health system stuck their noses, saying that those masks aren't good and they recomand to buy just the masks from pharmacies.

A smart move, but also stupid. And because the population is to scared from a virus and they bought all the masks in the pharmacies, puting their stocks outmost on 0. So the dealers are back on market and they are selling those masks on overprice. Smart move...

marți, 10 noiembrie 2009

Antiperspirants on pharmacies

I've saw a lot of farmacies that sold antiperspirants lately. I didn't knew why when i saw it the first time, but now i know. Apparently there is a new antiperspirant that have some good qualities for skin: antiperspirant maxim.

And because of the skin thing they sell them in pharmacies and drugstores and apparently they gain some profit of it.

What do you know about it ? Did you tried it?

duminică, 8 noiembrie 2009

What is biotechnology?

Biotechnology, in its most general meaning, is the use of biologic processes to create a product for human use and benefit. Today, when people use the term biotechnology, we usually think they mean the application of modern methods of manipulation of DNA (deoxyribonucleic acid), the genetic information of an organism, to make a product. In fact, biotechnology is ancient, providing the basis for making a wide range of products, including bread, cheese, beer, and wine. These early forms of biotechnology relied on fermentation, the breakdown by microorganisms of organic molecules, particularly sugars, into simpler compounds, often CO2 (carbon dioxide). In practice, fermentation involves holding the material under conditions that allow the microorganisms to increase in number, and to change the original material through chemical reactions inside the cells. The starting material in fermentation can be bread dough, made of flour, water, and yeast, or grape juice plus yeast.

Biotechnology in few words

Biotechnology, the use of biological organisms and processes to provide useful products in industry and medicine, is as old as cheese making and as modern as creating a plant-based energy cell or the newest treatment for diabetes. Everyday, newspaper articles proclaim a new application for biotechnology. Often, the media
raises alarms about the potential for new kinds of biotechnology to harm the environment or challenges our ethical values. As a result of conflicting information, sorting through the headlines can be a daunting task. These books are designed to allow you to do just that—by providing the right tools to help you to make better educated judgments.

The new biotechnologies share with the old a focus on helping people lead better, safer, and healthier lives. Older biotechnologies, such as making wine, brewing beer, and even making bread, were based on generations of people perfecting accidental discoveries.

The new biotechnologies are built on the explosion of discoveries made over the last 75 years about how living things work. In particular, how cells use genetic material to direct the production of proteins that compose them, and provide the engines used to produce energy needed to keep them alive. These discoveries have
allowed scientists to become genetic engineers, enabling them to move genes from one living organism to another and change the proteins made by the new organism, whether it is a bacterium, plant, mouse, or even a human.


Blogger Templates by Isnaini Dot Com. Powered by Blogger and Supported by Beautiful Architecture Homes